No Data
GKHT Medical Technology Co., Ltd.'s (SZSE:301370) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Guoke Hengtai (301370.SZ): Junlian Yikang has completed a shareholding reduction of 3%.
On December 23, Gelonghui reported that Guoke Hengtai (301370.SZ) announced that the company recently received a notice from Junlian Yikang regarding the completion of the Shareholding plan for Guoke Hengtai (Peking) Medical Technology Co., Ltd. As of the date of the announcement, Junlian Yikang has reduced its holdings in the company's shares by a total of 14,008,822 shares through centralized bidding, accounting for 3.0000% of the total share capital after excluding the repurchased shares. This Shareholding plan has been completed.
Guokexin Holdings (301370.SZ) intends to liquidate and deregister its subsidiary Guokexinhui.
Guoke Hengtai (301370.SZ) announced that the company will respectively hold the third board meeting on December 2, 2024...
Guokai Hengtai (301370.SZ) plans to acquire the remaining 40% equity of Guangdong Hengtai.
Guoke Hengtai (301370.SZ) announced that the company plans to use its own funds to acquire Zhanjiang Guangyuantai Medical Investment...
Guoke Hengtai (301370.SZ): basically has covered all categories of medical instruments, except for vascular intervention and orthopedics.
According to Gelonghui on November 27, Guoke Hengtai (301370.SZ) stated in their investor relations that the company has basically covered all categories of medical instruments. In addition to vascular intervention and orthopedics, the company will also focus on equipment, IVD, and other major categories of medical instruments, increasing the introduction of manufacturers for these two categories of products and corresponding additional services.
Guoke Hengtai (301370.SZ): Currently, the company's imported and domestically produced medical instruments revenue accounts for approximately 7:3.
On November 27, Gelonghui reported that Guoke Hengtai (301370.SZ) stated in their investor relations that the current revenue ratio from imported to domestic medical instruments is approximately 7:3. In terms of customer expansion, the company's innovative platform model has gained widespread recognition among clients, and it has established partnerships with over a hundred top domestic and foreign medical instrument manufacturers. The company provides high-standard services and high-quality deliveries through its nationwide integrated operation capabilities and full-chain service capabilities, efficiently meeting the needs of domestic and international clients. Looking ahead, the company will rely on its professional advantages in product service and established reputation in the industry.
Is GKHT Medical Technology Co., Ltd.'s (SZSE:301370) Recent Price Movement Underpinned By Its Weak Fundamentals?
